Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Calliditas Therapeutics
Company

Calliditas Therapeutics

Tracked across 1 events · 8 articles · First seen Feb 26, 2026 · Last active Feb 27, 2026

Sentiment
20
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 20
Business
Asahi Kasei Acquires Aicuris Anti-infective Cures
Calliditas Therapeutics is a nephrology subsidiary of Asahi Kasei. The acquisition of Aicuris is strategically adjacent to Calliditas's operations, as infection-related complications are a significant concern in nephrology patients.
Feb 26, 2026 · 8 articles
NEWSDESK
Track Calliditas Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.